Bayer claims CRISPR Patents for Gene-Editing Agreements | Plant and Seed Biology | Scoop.it
Bayer has signed a patent license agreement with ERS Genomics, that controls patents for the CRISPR-Cas9 system – a breakthrough gene-editing technology.